V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20205104 | 20167391 | 1.48 | 87.8 | Palliative (P) | 2019-10-13 | 2019-10-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100936904 |
| 20205113 | 20167392 | 1.54 | 55.6 | Palliative (P) | 2019-01-05 | 2019-01-05 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 100153699 |
| 20205117 | 20167393 | 1.69 | 109.35 | null | 2018-06-14 | 2018-06-14 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100430179 |
| 20205120 | 20167394 | 1.62 | 104 | Neo-adjuvant (N) | 2021-05-19 | 2021-06-23 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101016806 |
| 20205126 | 20167395 | 1.74 | 66.8 | Palliative (P) | 2020-09-19 | 2020-11-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100224569 |
| 20205153 | 20167396 | 1.78 | 63.6 | Adjuvant (A) | 2017-07-15 | 2017-07-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101105197 |
| 20205154 | 20167397 | 1.67 | 74.65 | null | 2020-03-16 | 2020-05-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100619946 |
| 20205165 | 20167398 | 1.62 | 74.15 | null | 2017-11-30 | 2017-12-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101534717 |
| 20205188 | 20167399 | 1.6 | 67.7 | Palliative (P) | 2020-12-05 | 2020-12-12 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101447317 |
| 20205199 | 20167400 | 1.59 | 55 | null | 2016-03-08 | 2016-03-12 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100374267 |
| 20205211 | 20167401 | 1.52 | 67.5 | Palliative (P) | 2016-12-27 | 2017-07-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101469892 |
| 20205213 | 20167402 | null | 64.7 | Neo-adjuvant (N) | 2021-10-28 | 2021-11-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101425269 |
| 20205215 | 20167403 | 1.5 | 78.7 | null | 2018-08-25 | 2018-09-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100591475 |
| 20205236 | 20167404 | 1.5 | 78 | Palliative (P) | 2019-08-22 | 2019-09-15 | Docetaxel | 02 | N | DOCETAXEL | 101399570 |
| 20205246 | 20167405 | 1.67 | 62.8 | Palliative (P) | 2018-10-12 | 2018-10-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101216523 |
| 20205267 | 20167406 | 1.66 | 103 | Palliative (P) | 2019-02-03 | 2019-02-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101771279 |
| 20205270 | 20167407 | 1.48 | null | Palliative (P) | 2021-04-19 | 2021-04-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100295625 |
| 20205283 | 20167408 | 2 | 75 | null | 2021-03-02 | 2021-07-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100124736 |
| 20205310 | 20167409 | 1.55 | 64.5 | Palliative (P) | 2018-04-17 | 2018-04-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100514143 |
| 20205319 | 20167410 | 1.85 | 71.7 | Palliative (P) | 2019-10-02 | 2019-12-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101650101 |
| 20205336 | 20167411 | 1.51 | 50 | null | 2021-01-04 | 2021-01-06 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100834311 |
| 20205340 | 20167412 | 1.58 | 64 | Palliative (P) | 2018-07-14 | 2018-07-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101037280 |
| 20205376 | 20167413 | 1.76 | 79 | null | 2018-08-15 | 2018-08-29 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101512553 |
| 20205383 | 20167414 | 1.82 | 74 | null | 2020-04-25 | 2020-08-20 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101840375 |
| 20205395 | 20167415 | 1.67 | 59.8 | null | 2019-08-06 | 2019-08-06 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101528676 |
| 20205407 | 20167416 | 1.69 | 59.8 | Adjuvant (A) | 2022-02-08 | 2022-02-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101294071 |
| 20205419 | 20167417 | 1.91 | 70.05 | null | 2019-06-30 | 2019-07-15 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101322094 |
| 20205432 | 20167418 | 1.74 | 85 | null | 2019-11-16 | 2019-11-20 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101569477 |
| 20205493 | 20167419 | 1.68 | 78.6 | null | 2019-09-21 | 2019-09-21 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100494257 |
| 20205495 | 20167420 | 1.83 | 79.6 | Palliative (P) | 2022-04-02 | 2022-04-08 | Docetaxel | 02 | N | DOCETAXEL | 100725127 |
| 20205503 | 20167421 | 1.69 | 44.8 | Palliative (P) | 2018-12-17 | 2019-01-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101005023 |
| 20205519 | 20167422 | 1.69 | 62.9 | null | 2017-02-26 | 2017-03-26 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100595208 |
| 20205527 | 20167423 | 1.6 | 62.45 | null | 2016-07-06 | 2016-07-20 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101319002 |
| 20205529 | 20167424 | 1.66 | 77 | Neo-adjuvant (N) | 2021-01-16 | 2021-01-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100850957 |
| 20205532 | 20167425 | 1.68 | 89.4 | Curative (C) | 2021-03-09 | 2021-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101377052 |
| 20205539 | 20167426 | 1.76 | 52.2 | Palliative (P) | 2018-04-06 | 2018-07-18 | Docetaxel | 2 | N | DOCETAXEL | 100663530 |
| 20205545 | 20167428 | 0 | 78.1 | null | 2018-01-30 | 2018-02-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100794463 |
| 20205577 | 20167429 | 1.66 | 89.9 | null | 2018-02-15 | 2018-08-10 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100685674 |
| 20205590 | 20167430 | 1.7 | 67 | Neo-adjuvant (N) | 2022-01-27 | 2022-01-31 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101258678 |
| 20205593 | 20167431 | 1.74 | 68.6 | Palliative (P) | 2022-03-26 | 2022-04-01 | Docetaxel | 02 | N | DOCETAXEL | 101017282 |
| 20205597 | 20167432 | 1.62 | 68.7 | null | 2019-01-10 | 2019-05-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100805225 |
| 20205602 | 20167433 | 1.89 | 87.35 | Palliative (P) | 2016-08-03 | 2016-08-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 100105443 |
| 20205608 | 20167434 | 1.84 | 78 | null | 2020-09-14 | 2021-04-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100851368 |
| 20205619 | 20167435 | 1.76 | 62.6 | Palliative (P) | 2020-03-22 | 2020-04-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101747743 |
| 20205632 | 20167436 | 1.67 | 107.5 | null | 2017-05-24 | 2017-06-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101826815 |
| 20205651 | 20167437 | 1.85 | 68.5 | null | 2020-04-11 | 2020-04-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101445870 |
| 20205681 | 20167438 | 1.76 | 87 | Palliative (P) | 2017-05-28 | 2017-06-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100828536 |
| 20205687 | 20167439 | 1.61 | 77.5 | Palliative (P) | 2017-03-22 | 2017-03-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101634730 |
| 20205699 | 20167440 | 1.67 | 64.55 | Palliative (P) | 2018-01-19 | 2018-03-02 | Docetaxel | 02 | N | DOCETAXEL | 100714137 |
| 20205709 | 20167441 | 1.68 | 82.2 | Palliative (P) | 2020-02-02 | 2020-05-05 | Docetaxel | N | N | DOCETAXEL | 100372344 |